Showing 20,021 - 20,040 results of 25,426 for search '(( significant ((clinical cases) OR (linear decrease)) ) OR ( significant decrease decrease ))', query time: 0.55s Refine Results
  1. 20021

    Table 6_The SlERF4-9-SlCDF1/3-SlAEC2/SlPIN5 module regulates tomato root morphogenesis.xlsx by ZhengFeng Fan (20950202)

    Published 2025
    “…The fresh weight, drought weight, number of primary lateral roots (LRs), average root diameter, and number of root tips were also decreased in the mutant. The findings suggest that SlERF4-9 plays a significant role in root growth and development. …”
  2. 20022

    Granola consumption with multiple prebiotics in Japanese participants increases <i>Bifidobacterium</i> abundance and improves stress and subjective sleepiness by Hiroyuki Sasaki (20851130)

    Published 2025
    “…</p><p dir="ltr"><b>Results</b> After 8 weeks, subjective insomnia scores and sleep onset and maintenance improved significantly, whereas the stress and mood disturbance scores decreased significantly. …”
  3. 20023

    Presentation 1_Immigration reduces selection in water microbial community assembly.pdf by Fen-Guo Zhang (736948)

    Published 2025
    “…However, on the 60th day, diversity significantly increased. The variation explained by the environment substantially decreased from the 13th to the 60th day. …”
  4. 20024

    Table 2_The SlERF4-9-SlCDF1/3-SlAEC2/SlPIN5 module regulates tomato root morphogenesis.xlsx by ZhengFeng Fan (20950202)

    Published 2025
    “…The fresh weight, drought weight, number of primary lateral roots (LRs), average root diameter, and number of root tips were also decreased in the mutant. The findings suggest that SlERF4-9 plays a significant role in root growth and development. …”
  5. 20025

    Assessing cell viability with WST-8 assay. by Shepard C. Moore (22537510)

    Published 2025
    “…Normalized viability differences between cell lines exposed to (A) 100 µg/mL and (B) 500 µg/mL of uranium oxide particulates; A549 shows significantly decreased viability compared to HBTEC (p = 0.0047) and HSAEC (p = 0.0026) at 100 µg/mL. …”
  6. 20026

    Data Sheet 1_Global, regional, and national time trends in falls and their predictions: an age-period-cohort analysis of the Global Burden of Disease Study 2021.pdf by Huan Jiang (1672375)

    Published 2025
    “…</p>Conclusion<p>Falls among older adults remain a persistent global issue, with significant regional and intra-regional disparities in falls mortality. …”
  7. 20027

    Data Sheet 4_Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disea... by Chenjing Xu (12109035)

    Published 2025
    “…</p>Conclusion<p>The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.…”
  8. 20028

    Data Sheet 1_Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease.pdf by Faruk Hossen (20275670)

    Published 2025
    “…Specifically, we found significant decreases in insulin receptor-α (IR-α) and insulin receptor-β (IR-β) expression, along with increased levels of phospho-insulin receptor substrate 1 at Ser307 [p-IRS-1 (Ser307)] and decreased levels of p-IRS-1 (Tyr895), compared to wild-type (WT) mice. …”
  9. 20029

    Data Sheet 2_Circulating tsRNAs serve as potential biomarkers for predicting postoperative delirium in elderly patients receiving lower extremity orthopedic surgery.docx by Angyang Cao (20938820)

    Published 2025
    “…</p>Methods<p>This study conducted a prospective case-control study of 158 elderly patients (≥60 years) undergoing orthopedic surgery. …”
  10. 20030

    Table 8_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  11. 20031

    Table 5_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  12. 20032

    Table 6_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  13. 20033

    Table 1_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.doc by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  14. 20034

    Establishment and validation of the prognostic risk model based on the anoikis-related genes in esophageal squamous cell carcinoma by Shasha Cao (337495)

    Published 2024
    “…The IC50 values of predicted drugs, in the case of Tozasertib 1096 and WIKI4 1940, were significantly variant between risk groups. …”
  15. 20035

    Table 3_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  16. 20036

    Table 9_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  17. 20037

    Supplementary Material for: Generalized Pustular Psoriasis Confers Increased Risk of Pyoderma Gangrenosum: First Population-Based Evidence by figshare admin karger (2628495)

    Published 2025
    “…Results: After matching, the GPP cohort (n = 44,187) had a significantly higher risk of PG than controls (n = 44,187; HR 5.14; 95% CI 2.77–9.53). …”
  18. 20038

    Table 2_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”
  19. 20039

    Data Sheet 1_Circulating tsRNAs serve as potential biomarkers for predicting postoperative delirium in elderly patients receiving lower extremity orthopedic surgery.docx by Angyang Cao (20938820)

    Published 2025
    “…</p>Methods<p>This study conducted a prospective case-control study of 158 elderly patients (≥60 years) undergoing orthopedic surgery. …”
  20. 20040

    Table 7_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls by Lian Tang (8446068)

    Published 2025
    “…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …”